rTMS with a two-coil array: Safety and efficacy for treatment resistant major depressive disorder

Background: Therapeutic repetitive Transcranial Magnetic Stimulation (rTMS) has emerged as a standard of care for individuals with major depressive disorder (MDD) who do not benefit from, or are unable to tolerate, antidepressant pharmacotherapy. Depth of stimulation is limited with currently approv...

Full description

Bibliographic Details
Main Authors: Linda L. Carpenter, Scott T. Aaronson, Gregory N. Clarke, Paul E. Holtzheimer, Clark W. Johnson, William M. McDonald, Elizabeth L. Stannard, M. Bret Schneider
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Brain Stimulation
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1935861X17308343